organ transplant recipients

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cutaneous Squamous Cell Carcinoma, Actinic Keratoses, Skin Cancer Trial in Boston, Saint Louis (Calcipotriol Only Product in

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +4 more
  • Calcipotriol Only Product in Cutaneous Dose Form
  • +2 more
  • Boston, Massachusetts
  • +1 more
Apr 5, 2022

Immunotherapy, Cutaneous Squamous Cell Carcinoma, Actinic Keratoses Trial in Boston, Saint Louis (Calcipotriol Only Product in

Not yet recruiting
  • Immunotherapy
  • +4 more
  • Calcipotriol Only Product in Cutaneous Dose Form
  • +2 more
  • Boston, Massachusetts
  • +1 more
Apr 5, 2022

Complement-activating Anti-human Leucocyte Antigen Donor

Completed
  • Organ Transplant Recipients
  • Graft survival and/or Rejection appearance
  • (no location specified)
Feb 15, 2018

Actinic Keratoses, Carcinoma, Squamous Cell, Organ Transplant Recipients Trial in Worldwide (Afamelanotide (CUV1647), Placebo)

Unknown status
  • Actinic Keratoses
  • +2 more
  • Afamelanotide (CUV1647)
  • Placebo
  • Brisbane, Queensland, Australia
  • +11 more
Dec 3, 2010